These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34529272)

  • 1. A practical guide on the use of imiquimod cream to treat lentigo maligna.
    Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
    Australas J Dermatol; 2021 Nov; 62(4):478-485. PubMed ID: 34529272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
    Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
    Australas J Dermatol; 2022 May; 63(2):e198-e199. PubMed ID: 35107826
    [No Abstract]   [Full Text] [Related]  

  • 4. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
    Swetter SM; Chen FW; Kim DD; Egbert BM
    J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
    Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
    Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical imiquimod immunotherapy in the management of lentigo maligna.
    Powell AM; Russell-Jones R; Barlow RJ
    Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lentigo maligna treated with 5% imiquimod cream].
    Martín T; Ojeda A; Martínez S; Vera A
    Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
    Powell AM; Robson AM; Russell-Jones R; Barlow RJ
    Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Videodermatoscopy of lentigo maligna treated with imiquimod.
    Micali G; Lacarrubba F; Nardone B; Nasca MR
    J Drugs Dermatol; 2008 Nov; 7(11):1077-80. PubMed ID: 19110742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
    Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
    Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should topical imiquimod be used for positive margins in lentigo maligna?
    Wang TS; Griffiths CC; Roman EM
    J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.
    Muir J; McCormack C; De'Ambrosis B; Brown H; Kennedy D; Louie B; Smithers BM
    Australas J Dermatol; 2022 May; 63(2):e197-e198. PubMed ID: 35262178
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
    Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens.
    Flores S; Luby NJ; Bowen GM
    JAMA Dermatol; 2018 Apr; 154(4):482-484. PubMed ID: 29453870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy.
    Brand FL; Seyed Jafari SM; Hunger RE
    Dermatology; 2019; 235(2):150-155. PubMed ID: 30554198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials.
    Astorino S; Astorre P; Pasquini P; Di Nunno D; Pellegrini F; Paolino G
    Dermatol Ther; 2019 Jan; 32(1):e12757. PubMed ID: 30285299
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
    Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
    Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.